Iannis Aifantis, Assistant Professor
(Ph.D. University of Paris, France, 1999)

webpage

Silvia Buonamici, Research Assistant Professor
(Ph.D. University of Bologna, Italy, 2002)

Silvia is working on Molecular Mechanisms of T cell leukemia induction and establishment
webpage

Alan Vest, Lab Manager
(B.A. Knox College, USA, 2003)

Katie Sawai, Graduate Student, Committee on Immunology, University of Chicago
(B.A. Carleton College, USA, 2003)

Katie is working on Cell cycle regulation in hematopoiesis: The role of the D-type cyclins

Ben Thompson, MSTP Student, Committee on Immunology, University of Chicago

Ben is working on ubiquitin ligase Fbw7 as a tumor supressor and regulator of stem cell self-renewal
(B.A. Knox College, USA, 2003)

“Linsey Reavie, Graduate Student NYU-SoM,
Linsey is studying the function of the Fbw7 ligase in hematopoiesis and leukemia
B.S. Arizona State University, 2005”

Jie Gao, Post-Doctoral Fellow
(Ph.D. Columbia University, USA, 2007)

Jie is working on Hedgehog signaling in hematopoiesis

Severine Cathelin, Post-Doctoral Fellow
(Ph.D. University of Bourgonne, France, 2006)

Severine is working on Notch signaling and its role in T cell leukemia

Kelly Moran, Post-Doctoral Fellow
(Ph.D. Georgetown University, USA, 2003)

Kelly is working on Cell cycle regulation and its role in hematopoiesis

Suqing Liu, Research Technician
(M.Sc. The Chinese Academy of Sciences, Kunming, China, 2004)

Suqing is working on Pathways controlling hematopoietic stem cell differentiation

Thomas Trimarchi, Reasearch Technician
(B.Sc. University of Vermont, USA, 2006)

Thomas is working on Notch signaling and T cell leukemia

"Julia Berthet, Undergraduare Rotation Student, Swarthmore College, USA"

 

ALUMNI:

Stephanie Graves, B. Sc. University of Illinois 2003,
(Currently: University of Chicago, Pritzker School of Medicine).
Abdeljabar El Andaloussi, PhD,
(Currently: Assistant Professor, Sherbrooke University, Montreal, Canada).
Malay Mandal, PhD,
(Currently:Post-doctoral Fellow, Department of Medicine, University of Chicago, USA)
Tomas Vilimas, PhD,
(Currently, Researcher, Glaxo-Smith-Kline, USA)